Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
2.519
+0.029 (1.18%)
Jan 23, 2025, 3:33 PM EST - Market open
Pasithea Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 23, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 8 | 19 | 39 | - |
| Market Cap Growth | -43.34% | -58.92% | -51.55% | - | - |
| Enterprise Value | -6 | -11 | -23 | 18 | - |
| Last Close Price | 2.42 | 7.40 | 12.83 | 35.40 | - |
| PS Ratio | - | - | - | 2572.19 | - |
| PB Ratio | 0.14 | 0.33 | 0.44 | 0.75 | - |
| P/TBV Ratio | 0.62 | 0.54 | 0.57 | 0.75 | - |
| EV/Sales Ratio | - | - | - | 1206.82 | - |
| Debt / Equity Ratio | - | 0.00 | 0.01 | - | - |
| Asset Turnover | - | - | - | 0.00 | - |
| Quick Ratio | 14.18 | 6.22 | 17.62 | 118.42 | 36.90 |
| Current Ratio | 14.81 | 6.34 | 18.15 | 119.17 | 37.55 |
| Return on Equity (ROE) | -68.24% | -47.07% | -24.97% | -8.41% | - |
| Return on Assets (ROA) | -40.93% | -28.02% | -15.98% | -10.52% | - |
| Return on Capital (ROIC) | -43.32% | -30.04% | -16.67% | -10.91% | - |
| Earnings Yield | -514.73% | -207.04% | -74.25% | -5.61% | - |
| FCF Yield | -502.03% | -174.58% | -73.52% | -8.25% | - |
| Buyback Yield / Dilution | 20.66% | 2.83% | -142.65% | -41.29% | - |
| Total Shareholder Return | 20.66% | 2.83% | -142.65% | -41.29% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.